Patents by Inventor LISHANTHI UDABAGE

LISHANTHI UDABAGE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using same
    Patent number: 9783599
    Abstract: The invention provides LM-1 antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions. The invention also provides antibodies, functional fragments, modified and variant forms that bind to LM-1 antigen (e.g., NONO/nmt55). Antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions are useful in treatment and diagnostic methods. One method includes treating metastasis of a neoplasia, tumor or cancer in a subject in need of treatment by administering to the subject an amount of a LM-1 antibody, an antibody that binds to LM-1 antigen, or a functional fragment thereof, effective to treat metastasis of the neoplasia, tumor or cancer in the subject.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: October 10, 2017
    Assignee: Patrys Limited
    Inventors: Heinz Peter Vollmers, Stephanie Ute Brandlein, Andreas Thalheimer, Leodevico L. Ilag, Barbara E. Power, Lishanthi Udabage, Frank Hensel, Frank Schoenen, Arndt-Rene Kelter, Christopher Garth Hosking
  • LM-Antibodies, Functional Fragments, LM-1 Target Antigen, and Methods for Making and Using Same
    Publication number: 20150071931
    Abstract: The invention provides LM-1 antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions. The invention also provides antibodies, functional fragments, modified and variant forms that bind to LM-1 antigen (e.g., NONO/nmt55). Antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions are useful in treatment and diagnostic methods. One method includes treating metastasis of a neoplasia, tumor or cancer in a subject in need of treatment by administering to the subject an amount of a LM-1 antibody, an antibody that binds to LM-1 antigen, or a functional fragment thereof, effective to treat metastasis of the neoplasia, tumor or cancer in the subject.
    Type: Application
    Filed: March 14, 2014
    Publication date: March 12, 2015
    Applicant: Patrys Limited
    Inventors: Heinz Peter Vollmers, Stephanie Ute Brandlein, Andreas Thalheimer, Leodevico L. Ilag, Barbara E. Power, Lishanthi Udabage, Frank Hensel, Frank Schoenen, Arndt-Rene Kelter, Christopher Garth Hosking
  • SAM-6 VARIANTS, TARGET AND METHODS OF USE
    Publication number: 20110207917
    Abstract: The invention provides polypeptide, nucleic acid and other compositions. Polypeptide, nucleic acid and other compositions are useful in treatment and diagnostic methods. One treatment method includes inhibiting growth or proliferation of hyperproliferative cells or inducing regression of hyperproliferative cells, such as cells of a cellular hyperproliferative disorder, or reducing levels of LDL or oxLDL.
    Type: Application
    Filed: February 9, 2010
    Publication date: August 25, 2011
    Applicant: PATRYS LIMITED
    Inventors: Leodevico I. Ilag, Barbara Power, Lishanthi Udabage
  • LM-1 ANTIBODIES, FUNCTIONAL FRAGMENTS, LM-1 TARGET ANTIGEN, AND METHODS FOR MAKING AND USING SAME
    Publication number: 20100322936
    Abstract: The invention provides LM-1 antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions. The invention also provides antibodies, functional fragments, modified and variant forms that bind to LM-1 antigen (e.g., NONO/nmt55). Antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions are useful in treatment and diagnostic methods. One method includes treating metastasis of a neoplasia, tumor or cancer in a subject in need of treatment by administering to the subject an amount of a LM-1 antibody, an antibody that binds to LM-1 antigen, or a functional fragment thereof, effective to treat metastasis of the neoplasia, tumor or cancer in the subject.
    Type: Application
    Filed: June 15, 2009
    Publication date: December 23, 2010
    Applicant: PATRYS LIMITED
    Inventors: HEINZ PETER VOLLMERS, STEPHANIE UTE BRANDLEIN, ANDREAS THALHEIMER, LEODEVICO L. ILAG, BARBARA E. POWER, LISHANTHI UDABAGE, FRANK HENSEL, FRANK SCHOENEN, ARNDT-RENE KELTER, CHRISTOPHER GARTH HOSKING